A phase 3 trial found that Eli Lilly's tirzepatide significantly reduced the risk of progression to Type 2 diabetes in prediabetic adults over a three-year period. Nearly 99% of individuals treated ...

A new study found that over 800 million adults have diabetes worldwide — almost twice as many as previous estimates have ...

The International Diabetes Federation (IDF) is drawing up new guidelines for the treatment of Type 2 diabetes in consultation with a global expert panel. These guidelines are being evaluated ...

The symptoms of the condition mean more serious ailments can arise such as serious foot problems ulcers, infections, and bone and joint pain ...

Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...

The rise in type 2 diabetes cases globally presents opportunities for growth in the market for GLP-1 drugs like Ozempic and ...

Discover how researchers from PGI and NABI are unlocking the anti-diabetic properties of ginger, leading to innovative ...

Type 2 diabetes interferes with your body’s ability to use glucose for energy, leading to fatigue. A study in the Industrial ...

The rise in type 2 diabetes has become a significant public health concern in recent years. This form of diabetes happens ...